Dana Investment Advisors Inc. Decreases Stake in Integer Holdings Co. (NYSE:ITGR)

Dana Investment Advisors Inc. cut its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 5.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 71,470 shares of the medical equipment provider’s stock after selling 4,124 shares during the period. Dana Investment Advisors Inc. owned about 0.21% of Integer worth $9,471,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of ITGR. Loomis Sayles & Co. L P grew its stake in Integer by 3.0% during the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock valued at $69,943,000 after purchasing an additional 15,446 shares in the last quarter. Jane Street Group LLC boosted its stake in shares of Integer by 23.3% during the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after buying an additional 28,572 shares during the last quarter. Verition Fund Management LLC increased its stake in shares of Integer by 17.4% in the third quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider’s stock worth $451,000 after buying an additional 515 shares during the last quarter. Versant Capital Management Inc raised its holdings in Integer by 98.4% in the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after acquiring an additional 183 shares in the last quarter. Finally, KBC Group NV boosted its stake in Integer by 83.3% during the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider’s stock valued at $212,000 after acquiring an additional 726 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Price Performance

Shares of ITGR opened at $122.87 on Thursday. Integer Holdings Co. has a 12 month low of $107.11 and a 12 month high of $146.36. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The stock has a fifty day moving average price of $136.01 and a 200 day moving average price of $132.95. The company has a market cap of $4.13 billion, a P/E ratio of 36.57, a PEG ratio of 1.72 and a beta of 1.13.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The firm had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. On average, research analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Analyst Ratings Changes

Several research firms have recently weighed in on ITGR. KeyCorp boosted their target price on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Truist Financial upped their price objective on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Oppenheimer downgraded Integer from an “outperform” rating to a “market perform” rating in a report on Friday, February 21st. Citigroup boosted their price target on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a report on Wednesday, December 11th. Finally, Wells Fargo & Company restated an “overweight” rating and set a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $147.67.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.